AllPennyStocks.com DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data

Definium Therapeutics, which develops treatments for mental health conditions, faces high expectations for its late-stage Voyage study of DT120.

Other Penny Stock Movers

This Microcap Just Proved Its First Profitable Quarter Wasn't a Fluke
Curaleaf Eyes Aurora Cannabis in Deal That Could Reshape the Global Cannabis Market
Scandium Explorer Jumps 15% on Shift from Metallurgical Sampling to Extension Drilling
Most Popular
{{ index + 1 }}


Back to Top